Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Extended report

Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry

Authors

E Kunisch PubMed articles Google scholar articles
R Fuhrmann PubMed articles Google scholar articles
A Roth PubMed articles Google scholar articles
R Winter PubMed articles Google scholar articles
W Lungershausen PubMed articles Google scholar articles
R W Kinne PubMed articles Google scholar articles

Correspondence to:
Dr R W Kinne
Experimental Rheumatology Unit, Friedrich Schiller University Jena, Hans-Knöll-Str 2, D-07745 Jena, Germany; raimund.w.kinnerz.uni-jena.de

Citation

Kunisch E, Fuhrmann R, Roth A, et al

Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry

Annals of the Rheumatic Diseases 2004;63:774-784.

Publication history

Accepted September 9, 2003
First published June 11, 2004.

Online issue publication

October 25, 2017

Copyright information

Copyright 2004 by Annals of the Rheumatic Diseases